NCT00424177View on ClinicalTrials.gov

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

PHASE2CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

November 30, 2008

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG

eltrombopag

experimental

Trial Locations (3)

13353

GSK Investigational Site, Berlin

30625

GSK Investigational Site, Hanover

125167

GSK Investigational Site, Moscow

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY